WAVE LIFE SCIENCES LTD. Earnings Per Share (Diluted)
WAVE LIFE SCIENCES LTD. (WVE) reported Earnings Per Share (Diluted) of -$0.34 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-07-30
- WAVE LIFE SCIENCES LTD. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.34.
- WAVE LIFE SCIENCES LTD. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.13.
- WAVE LIFE SCIENCES LTD. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.29, a 263.05% decline year-over-year.
- WAVE LIFE SCIENCES LTD. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.32.
- WAVE LIFE SCIENCES LTD. earnings per share, diluted for fiscal 2025 was -$1.21.
- WAVE LIFE SCIENCES LTD. earnings per share, diluted for fiscal 2024 was -$0.70.
- WAVE LIFE SCIENCES LTD. earnings per share, diluted for fiscal 2023 was -$0.54.
- WAVE LIFE SCIENCES LTD. earnings per share, diluted for fiscal 2022 was -$2.05.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.34 10-Q · filed 2026-07-30 | -$0.47 10-Q · filed 2026-07-30 | -$0.76 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-07-30 |
| 2026-03-31 | -$0.13 10-Q · filed 2026-04-28 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$1.03 derived: net income ÷ weighted average shares · filed 2026-07-30 |
| 2025-12-31 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.92 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$1.21 10-K · filed 2026-02-26 |
| 2025-09-30 | -$0.32 10-Q · filed 2025-11-10 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$0.92 10-Q · filed 2025-11-10 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-07-30 |
| 2025-06-30 | -$0.31 10-Q · filed 2026-07-30 | -$0.60 10-Q · filed 2026-07-30 | -$0.42 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$0.84 derived: net income ÷ weighted average shares · filed 2026-07-30 |
| 2025-03-31 | -$0.29 10-Q · filed 2026-04-28 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$0.52 derived: net income ÷ weighted average shares · filed 2026-07-30 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-07-30 |
| 2024-12-31 | $0.18 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.70 10-K · filed 2026-02-26 |
| 2024-09-30 | -$0.47 10-Q · filed 2025-11-10 | -$0.72 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$0.97 10-Q · filed 2025-11-10 | -$1.14 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2024-06-30 | -$0.25 10-Q · filed 2025-07-30 | -$0.50 10-Q · filed 2025-07-30 | -$0.66 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.62 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2024-03-31 | -$0.24 10-Q · filed 2025-05-08 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-02-26 |
| 2023-12-31 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.54 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.07 10-Q · filed 2024-11-12 | -$0.13 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$0.39 10-Q · filed 2024-11-12 | -$0.83 derived: net income ÷ weighted average shares · filed 2025-03-04 |
| 2023-06-30 | -$0.20 10-Q · filed 2024-08-08 | -$0.47 10-Q · filed 2024-08-08 | -$0.92 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$1.33 derived: net income ÷ weighted average shares · filed 2025-03-04 |
| 2023-03-31 | -$0.27 10-Q · filed 2024-05-10 | -$0.72 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$1.14 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$1.70 derived: net income ÷ weighted average shares · filed 2025-03-04 |
| 2022-12-31 | -$0.46 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$0.88 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$1.46 derived: net income ÷ weighted average shares · filed 2025-03-04 | -$2.05 10-K · filed 2025-03-04 |
| 2022-09-30 | -$0.42 10-Q · filed 2023-11-09 | -$1.00 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.60 10-Q · filed 2023-11-09 | -$2.20 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-06-30 | -$0.62 10-Q · filed 2023-08-03 | -$1.25 10-Q · filed 2023-08-03 | -$1.85 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.05 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2022-03-31 | -$0.62 10-Q · filed 2023-05-03 | -$1.23 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$1.40 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.15 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2021-12-31 | -$0.61 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$0.76 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.52 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$2.36 10-K · filed 2023-03-23 |
| 2021-09-30 | -$0.12 10-Q · filed 2022-11-10 | -$0.89 derived: net income ÷ weighted average shares · filed 2022-11-10 | -$1.75 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$0.78 10-Q · filed 2022-08-11 | -$1.65 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |